Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

428 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Does long-term itraconazole prophylaxis result in in vitro azole resistance in mucosal Candida albicans isolates from persons with advanced human immunodeficiency virus infection? The National Institute of Allergy and Infectious Diseases Mycoses study group.
Goldman M, Cloud GA, Smedema M, LeMonte A, Connolly P, McKinsey DS, Kauffman CA, Moskovitz B, Wheat LJ. Goldman M, et al. Among authors: kauffman ca. Antimicrob Agents Chemother. 2000 Jun;44(6):1585-7. doi: 10.1128/AAC.44.6.1585-1587.2000. Antimicrob Agents Chemother. 2000. PMID: 10817713 Free PMC article. Clinical Trial.
Histoplasmosis.
Wheat LJ, Kauffman CA. Wheat LJ, et al. Among authors: kauffman ca. Infect Dis Clin North Am. 2003 Mar;17(1):1-19, vii. doi: 10.1016/s0891-5520(02)00039-9. Infect Dis Clin North Am. 2003. PMID: 12751258 Review.
Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
McKinsey DS, Wheat LJ, Cloud GA, Pierce M, Black JR, Bamberger DM, Goldman M, Thomas CJ, Gutsch HM, Moskovitz B, Dismukes WE, Kauffman CA. McKinsey DS, et al. Among authors: kauffman ca. Clin Infect Dis. 1999 May;28(5):1049-56. doi: 10.1086/514744. Clin Infect Dis. 1999. PMID: 10452633 Clinical Trial.
Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS.
Johnson PC, Wheat LJ, Cloud GA, Goldman M, Lancaster D, Bamberger DM, Powderly WG, Hafner R, Kauffman CA, Dismukes WE; U.S. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Johnson PC, et al. Among authors: kauffman ca. Ann Intern Med. 2002 Jul 16;137(2):105-9. doi: 10.7326/0003-4819-137-2-200207160-00008. Ann Intern Med. 2002. PMID: 12118965 Free article. Clinical Trial.
Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group.
Wheat J, MaWhinney S, Hafner R, McKinsey D, Chen D, Korzun A, Shakan KJ, Johnson P, Hamill R, Bamberger D, Pappas P, Stansell J, Koletar S, Squires K, Larsen RA, Cheung T, Hyslop N, Lai KK, Schneider D, Kauffman C, Saag M, Dismukes W, Powderly W. Wheat J, et al. Am J Med. 1997 Sep;103(3):223-32. doi: 10.1016/s0002-9343(97)00151-4. Am J Med. 1997. PMID: 9316555 Free article.
Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus-infected persons.
Hajjeh RA, Pappas PG, Henderson H, Lancaster D, Bamberger DM, Skahan KJ, Phelan MA, Cloud G, Holloway M, Kauffman CA, Wheat LJ; National Institute of Allergy and Infectious Diseases Mycoses Study Group. Hajjeh RA, et al. Among authors: kauffman ca. Clin Infect Dis. 2001 Apr 15;32(8):1215-20. doi: 10.1086/319756. Epub 2001 Mar 26. Clin Infect Dis. 2001. PMID: 11283812
428 results